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Aim To attempt to develop a model of predictors for qual-
ity of the process of cardiovascular prevention in patients 
at high risk of cardiovascular disease (CVD).
Methods We formed a random sample of patients from a 
stratified sample of 36 family practice registers of patients 
at high risk of CVD without diabetes and without estab-
lished CVD. Data were gathered by chart audit and ques-
tionnaires about patient and practice characteristics. We 
defined the process of care as a dependent variable by 
principle component analysis and tested the relationship 
of the process with several independent variables (family 
physicians’, patients’, and practice characteristics). To study 
the effects of independent variables (predictors) on the 
process of care we carried out multilevel regression analy-
sis with the patients constituting the lower level and nest-
ed within the family physician/practice (the second level).
Results  Multilevel  regression  analysis  included  645  pa-
tients from 36 practices (74.1% from the final sample). Pa-
tients’ characteristics that predicted the higher-quality pro-
cess of CVD prevention were younger age (t = -4.94, 95% 
confidence interval [CI] -0.018 to -0.008) and lower socio-
economic status (t = -2.18, 95%CI -0.195 to -0.010). Practice 
characteristics that predicted the higher-quality process of 
CVD prevention were smaller practice size (t = 2.83, 95% CI 
0.063 to 1.166), a good information system for CVD preven-
tion (t = 3.15, 95% CI 0.030 to 0.282), and the organization 
of education on CVD prevention (t = 3.19, 95%CI 0.043 to 
0.380).
Conclusion This study shows that the quality of cardio-
vascular prevention could be measured as a composite 
outcome and future studies should further develop this 
approach and test the impact of several practice/patient 
characteristics on the quality of CVD prevention with the 
international data.
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Prevention of cardiovascular diseases (CVD) is an impor-
tant task for family physicians. While patients with a low 
risk of CVD profit mostly from public health activities, high 
risk patients also need preventive activities provided by 
their family physicians (1,2). In the countries with a nation-
al program of CVD prevention (Slovenia is one of them), 
these activities and procedures can be highly standardized 
(3) and, therefore, should be easily measurable. The Slove-
nian national preventive program for CVD was launched 
in 2001 and requires preventive check-ups for the defined 
age groups of patients (women from 45 to 70 years and 
men from 35 to 65 years). Eighty percent of the target 
group in every practice needs to go through the program 
in 5 years, and a register of high risk patients is created in 
each practice and collected on the national level. The pre-
ventive activities consist of two parts: the first part includes 
a health check-up with determination of risk factors (infor-
mation on life-style, clinical exam, laboratory tests of lipids 
and fasting blood glucose) and the second part includes 
the  referral  of  patients  at  high  risk  to  preventive  work-
shops, for example for healthy weight reduction, smoking 
cessation, etc.
Although there is some evidence on several isolated as-
pects of CVD prevention in Slovenia (4-6), a comprehen-
sive and systematic approach for measuring its quality 
and actual outcomes is still not available. Therefore, we 
aimed to develop an integral statistically evaluated pre-
sentation of the process of cardiovascular prevention and 
determine the variables that influence it. Post-hoc anal-
yses were performed on patients at a high risk for coro-
nary diseases using Slovenian data from the international 
EPA-Cardio study, a cross-sectional study conducted in 9 
European countries that had developed quality indicators 
for cardiovascular prevention on the international level (7) 
and evaluated the quality of cardiovascular prevention for 
high-risk patients (8).
PARticiPAnts AnD methoDs
Participants
Our aim was to include a sample of 1080 patients at high-
risk of developing of CVD in the next decade, ie, 30 pa-
tients per practice from 36 stratified randomized practic-
es in Slovenia. The practice was defined as the smallest 
location or organizational unit of single or several con-
nected practices that could be a part of a larger health 
care center. The response rate of the practices was 64% 
(out of 56 invited, 36 agreed to participate). The practic-
es were stratified according to size (small with up to two 
working family physicians [FP] at the same location and 
large ones with three or more FPs) and urbanization lev-
el (urban practices in settlements with more than 30 000 
inhabitants and rural in settlements of 30 000 inhabit-
ants or fewer). The practices from the four stratification 
groups were chosen by a random number table. Each 
practice declining to participate had been replaced by a 
practice under a random number from the same stratifi-
cation group until 36 practices agreed to participate. Pa-
tients were chosen by a set of random numbers from the 
computerized register of high-risk patients, which every 
Slovenian practice that follows the National Program of 
CVD Prevention has to keep. Risk assessment in the pro-
gram (and for the recruitment of patients in this study) 
is based on using validated CVD Framingham risk score. 
High risk for CVD was set at a ≥20% predicted morbidity 
rate in the next 10 years calculated by the Framingham 
risk chart. The Framingham risk chart is used by nation-
al agreement, although no local validation studies have 
been performed. We excluded coronary and diabetes pa-
tients as their preventive activities and medical care differ 
from the studied group. Detailed protocol of the interna-
tional EPA-Cardio study is described elsewhere (8).
calculations of the power of the study
A medium level (0.15) of effect size was chosen for un-
known R2. Based on the estimation of the linear regression 
analysis sample size with 24 predictor variables and a me-
dium level of the effect size, a sample of 250 participants 
would be needed in order to achieve 80% power for sta-
tistical analysis with an α level of 0.05 (9). Furthermore, the 
sample needed to be larger than what the above calcula-
tion predicts, because of clustering in the data set: patients 
treated by the same FP are likely to be more similar than 
patients treated by different FPs. To account for this clus-
tering, we used a multilevel analysis, which achieves lower 
power than a simple linear regression on disaggregated 
covariates would.
methods
The data were collected using four questionnaires from 
June 2008 to January 2009. The patients’ data were gath-
ered from the medical records with an audit form. In the 
audit,  we  used  previously  validated  quality  indicators, 
which were developed as a first part of the EPA-Cardio 
project (web-extra material) (7). The audit form includ-
ed questions about the detection and the level of PUBLIC HEALTH 720 Croat Med J. 2011; 52: 718-27
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cardiovascular risk factors, as well as their management – 
especially advice about changes of lifestyle. Patients an-
swered  the  questionnaires  on  their  demographics  and 
lifestyle, self-rated health, and use of health services. Phy-
sicians answered questionnaires on practice characteris-
tics, organization, information technology, and workload. 
We also performed a semi-structured interview with each 
physician on his/her preventive work.
For the purpose of analysis, we subdivided the process 
of  CVD  prevention  into  several  consecutive  steps.  The 
data for the steps 1,3, and 4 were derived from the prac-
tice questionnaire, whereas the data for the steps 2 and 
5 were derived from the patients’ records. For each step, a 
compound variable was calculated by adding the number 
of positive answers of the original dichotomized YES/NO 
variables, with a higher value of a compound variable im-
plying a better CVD prevention process. This represented a 
categorization of the items into clinically logical domains 
of cardiovascular prevention. Frequency distribution was 
made for each compound variable:
1. Identification of patients for cardiovascular prevention 
(0-9 points). This compound variable represents a number 
of “yes” answers to the questions about several methods 
of screening of patients for CVD prevention: systematic 
screening for each age group, opportunistic screening for 
special groups of patients such as overweight patients, pa-
tients with diabetes, smokers, hypertensive patients, spe-
cific ethnic groups, and low socioeconomic status patients, 
and screening on patient’s demand.
2. Identification of risk factors (0-6 points). This compound 
variable represents a number of “yes” answers to the ques-
tions about detection of several risk factors for CVD: smok-
ing status, physical activity, calculated body mass index, 
measurement of blood pressure, identification of choles-
terol level, and blood glucose level.
3. CVD risk assessment (0-13 points). This compound vari-
able represents how the practice determines cardiovascu-
lar risk: a number of known risk factors that are included in 
risk assessment; implementation of CVD risk assessment in 
the practice; the inclusion of the following patient data in 
CVD risk assessment – age, sex, smoking status, blood pres-
sure, diabetes, family history on CVD, diagnosis on CVD, al-
cohol consumption, body mass index, lipid status, and 
fasting/random blood glucose or oral glucose tolerance 
test; and the use of standardized risk assessment tools 
in the practice.
4. Process of risk management – physicians (0-4 points). 
This compound variable represents a number of “yes” an-
swers to the questions about general approach to educa-
tion on lifestyle: offering written information on healthy 
lifestyles, advice on Web sites with lifestyle advice, advice 
on local physical exercise programs, and education on chil-
dren’s lifestyle.
5. Process of risk management – patients (0-6 points). This 
compound variable represents a number of “yes” answers 
to the questions about the physicians’ advice for CVD pre-
vention: data in patients’ medical records in the last 15 
months; advice on smoking, physical activity, and nutri-
tion, motivation for quitting smoking, and follow-ups on 
quitting smoking.
We also determined several independent variables (sev-
eral characteristics of physicians, patients, and practice) to 
test their impact on the process quality of CVD prevention. 
Physicians’ characteristics were age, sex, and professional 
activity on the projects of CVD prevention.
Practice  characteristics  were  several  dichotomous  and 
compound variables: size (small/big) and location (urban/
rural),  information  system  for  cardiovascular  prevention 
(measured by a compound variable for the completeness 
of the information in medical records such as problem list, 
data on regular medication, smoking status, hypertension, 
diabetes, and/or CVD; system for classification of the dis-
ease; standardized risk assessment method), organization 
of prevention (measured by a compound variable with the 
active screening of risk patients and a system for recalling 
patients), availability of the information on CVD prevention 
for patients, involvement in public health projects on CVD 
prevention, organization of the education of CVD preven-
tion (compound variable on the practice’s organizing edu-
cation in which the physicians and nurses take part), and 
workload (number of patients on the practice list).
Patients’ characteristics were age, sex, education (≤9, 10-13, 
>13 years), employment status (unemployed/employed, 
retired,  or  unable  to  work),  self-evaluation  of  socioeco-
nomic status (low, middle, high), ethnic origin (Slovenian/
other), self-assessment of health (5-point ordinal scale from 
excellent = 1 point to bad health = 5 points), self-assessed 
health related to the quality of life (EuroQol instrument – 
a questionnaire with five domains: mobility, self-care, ev-
ery-day activities, pain, anxiety/depression – each domain 
has 3 levels, 1 point for the best status and 3 points for the 
worst), the length in years of attachment to the same prac-721 Petek et al: Predictors of the quality of cardiovascular prevention
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tice, frequency of patients’ visits to the practice per year, 
the presence of chronic diseases that represent risk fac-
tors for CVD (number of “yes” answers), and adherence to 
prescribed medication therapy (number of “yes” answers in 
the questionnaire) (10).
Independent compound variables were constructed by a 
sum of individual variables with a “yes” answer that repre-
sented a good approach to cardiovascular prevention. Di-
chotomous variables were coded yes = 1 and no = 0. Co-
variates were selected according to the hypotheses. For 
practice characteristics, we based the selection on a previ-
ous study on quality in primary care practices (11). For each 
variable in a hypothesis an empirical variable was created.
statistical analysis
The process of CVD prevention was measured by five com-
pound  variables  described  above.  Principal  component 
analysis (PCA) was used to obtain an overall measure of the 
process of CVD prevention in order to reduce the number 
of variables and to detect structure in the relationship be-
tween variables. By PCA we measured underlying compo-
nents for five compound variables. The number of com-
ponents was determined by the highest eigenvalue in the 
scree plot and also by component loadings, which are cor-
relations between the component and each variable. The 
PCA analysis was performed using the statistical package 
SPSS, 17.0 (SPSS Inc., Chicago, IL, USA).
To  analyze  the  relationship  of  physicians’,  patients’,  and 
practice characteristics and the process of CVD prevention, 
we used a random intercept model. A multilevel model ac-
counts for correlation in the dependent variable for pa-
tients treated by the same FP (12). The patients constituted 
the lower level nested within the FP/practice; the FP/prac-
tice presented the same level in our model, because we al-
ways had exactly one FP per practice in the sample. Model 
0 contained no covariates, model 1 contained patient-level 
covariates, and model 2 contained covariates measured at 
the FP/practice level in addition to the patient-level cova-
riates.
We specified the fitted model separately for each of the 
two levels. The patient-level model closely resembled the 
simple linear regression model. We gradually entered the 
explanatory covariates into the model and examined the 
effect on each variance component. The variance com-
ponents  and  model  comparisons  are  given  in Table  1. 
The confidence intervals for the variance components are 
given in parentheses and were obtained by profiling the 
likelihood. We performed the estimation in the GNU gen-
eral Public License software R, using the package lme4a 
(13,14). The second row of the rightmost part of Table 1 
shows the results of the likelihood ratio test of Model 1 
against Model 0: Model 1 fits the data considerably better 
(χ2 = 43.4, P < 0.001), which is also indicated by other mea-
sures of fit, eg, the Akaike information criterion decreasing 
from 1106.7 to 1089.3.
Adding the covariates measured at the FP/practice lev-
el to the model further improves the model fit (χ2 = 23.3, 
P = 0.016):  the  rightmost  part  the  third  row  of  Table  1 
shows the results of the likelihood ratio test of Model 2 
against Model 1. The effect on the intercept variance was 
dramatic – it was reduced nearly by half, indicating that the 
covariates measured at the FP and practice level explain a 
substantial part of the variability between FPs/practices in 
the process of CVD prevention. The significance of effects 
in the model was not evaluated in terms of P values, since 
calculating P values for coefficients in a multilevel model 
can be problematic (14). Rather, we examined the signifi-
cance on the basis of 95% confidence intervals that were 
obtained by profiling the likelihood: if the interval does not 
contain the zero-value, we can be reasonably certain that 
the direction of the effect is stable.
tAble 1. components of the “cardiovascular disease process” variance and model comparisons obtained by entering patient charac-
teristics and practice/physician characteristics covariates in two levels of regression analysis.
Variance
model Description
intercept 
(95% ci)*
residual 
(95% ci)*
Akaike  
information criterion log-likelihood Deviance χ2 test
Degrees of 
freedom P
0 no covariates 0.679 
(0.437-1.129)
0.261 
(0.234-0.293)
1106.7 -550.4 1100.7
1 patient-level 
covariates
0.678 
(0.436-1.129)
0.243 
(0.218-0.272)
1089.3 -528.6 1057.3 43.4 13 0.000
2 all covariates 0.349 
(0.222-0.584)
0.243 
(0.218-0.272)
1088.0 -517.0 1034.0 23.3 11 0.016
*ci – confidence interval.PUBLIC HEALTH 722 Croat Med J. 2011; 52: 718-27
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Results
sampling
We approached 1080 patients with high CVD risk in 36 
practices. The questionnaire was returned by 897 patients, 
for whom the data were collected from the records. We ex-
cluded 26 patients because of unclear coding or not fulfill-
ing of the inclusion criteria. The final sample consisted of 
871 patients (80.6% response rate). However, only 645 pa-
tients entered multilevel regression analysis while the rest 
had missing data (74.1% of the final sample). We excluded 
the units that had a missing value in at least one of the 
variables in the model. Twenty-two patients were exclud-
ed because of unavailable data from the chart audit and 
the following 72 patients because they did not complete 
the patient survey. The rest of the 226 exclusions oc-
curred because of sporadic missing in the variables 
(Figure 1). The original sample and the sample that entered 
linear multiple regression analysis were similar in structure 
(Table 2).
Patient characteristics
The mean age of the participants was 62.9 years (95% con-
fidence interval [CI] 62.1 to 63.7), 62.0 years (95% CI 61.1 
to 63.0) for men and 64.5 years (95% CI 63.2 to 65.9) for 
women. Most of the patients finished high school (43.4%). 
Only 3.7% were unemployed, others were employed or 
retired or unable to work, and 73.3% estimated their so-
cioeconomic status as average (Table 2). The majority of 
the patients self-rated their health as good (42.8%), 37.9% 
as fair, and 9.1% as poor. More than two thirds (68.1%) of 
patients were visiting the same practice ≥13 years. There 
were 37.6% of patients who were visiting the practice 4-5 
times a year and 22.8% 2-3 times a year.
Practice characteristics
The 23 included practices were small – two or fewer full 
time equivalent FPs working at the same location (18 in 
Figure 1.
Flowchart of the sampling process of practices and patients enrolled in 
the study on predictors of quality of cardiovascular prevention in slo-
venia.
tAble 2. Demographic characteristics of the patients enrolled 
in the study on predictors of quality of cardiovascular preven-
tion in slovenia.
Demographic
characteristics
no. (%)of patients 
who entered 
multilevel analysis
sex (n = 837)
women 224 (34.7)
men 421 (65.3)
education (n = 757)
elementary school or less 231 (35.8)
high school 280 (43.4)
university 134 (20.8)
employment status (n = 784)
unemployed   24 (3.7)
other* 621 (96.3)
socioeconomic status (n = 750)
low 145 (22.5)
middle 473 (73.3)
high 27 (4.2)
marital status (n = 779
married 498 (77.2)
other† 147 (22.8)
ethnic origin (n = 750)
Slovenian 603 (93.5)
other   42 (6.5)
*Retired, home-maker, employed, self-employed, unable to work.
†Divorced, widow/er, single.723 Petek et al: Predictors of the quality of cardiovascular prevention
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suburban areas and 5 in urban areas) and 27 were located 
in the suburban areas (18 small and 9 big). The mean num-
ber of the patients on the practice list was 2096 (95% CI 
2038.7 to 2153.2). Approximately three quarters (n = 28) of 
FPs were women with the average age of 47.1 years (95% 
CI 46.5 to 47.6), while their male colleagues were on the 
average 53.8 years old (95% CI 53.0 to 54.5). The practices 
were distributed randomly throughout the country.
Principal component analysis
We applied the PCA on the compound variables describing 
the process of CVD prevention (Table 3) in order to identify 
possible  underlying  variables,  ie, “common  denominators” 
that would enable easier interpretation of the prevention 
process. The loadings of the original five compound variables 
on the first principal component were positive and showed 
relatively high values (above 0.45) (Table 4). We determined 
the number of components by the highest eigenvalue in 
the diagram and also by the component loadings, which are 
correlations between component and each variable.
Based on the scree plot (Figure 2), we decided to retain 
only the first principal component, explaining 36.1% of 
the total variance. The distribution of the dependent vari-
able “process” was normal, confirmed by the frequency 
histogram and by the Kolmogorov-Smirnov test (Z = 0.97; 
P = 0.30).
multilevel analysis
The impact of the characteristics of physicians, practices, 
and  patients  on  the  process  of  CVD  prevention  is  pre-
sented in Table 5. Patients’ characteristics that were posi-
tive predictors of the process of CVD prevention were only 
younger  age  (-0.013;  95%  CI,  -0.018  to  -0.008,  t = -4.94) 
and lower socioeconomic status (-0.103; 95% CI, -0.195 to 
-0.010, t = -2.18). Practice characteristics that were predic-
tors of the process of CVD prevention were smaller size 
(0.615; 95% CI, 0.063-1.166, t = 2.83), a good information 
system  for  CVD  prevention  (0.156;  95%  CI,  0.030-0.282, 
t = 3.15), and the organization of education on CVD pre-
vention (0.212; 95% CI, 0.043-0.380, t = 3.19). Two practice 
characteristics that showed borderline importance were 
cooperation in programs of CVD prevention and urban 
practice location.
Discussion
We found that particularly important factors for the CVD 
prevention were information system of the practice and 
the ability to capture the complete data in medical records, 
such as problem list, medication list, or records on risk fac-
tors. Another practice characteristic that improved the pro-
cess of the CVD prevention was organization of continuous 
tAble 3. the frequency distribution and standard deviation of 
the five compound variables of the process of cardiovascular 
disease prevention in 871 high risk patients for cardiovascular 
disease enrolled in cross-sectional study in slovenia
compound variable 
(number of original variables) 
no. of points 
(mean ± standard 
deviation)
Identification of patients (9) 4.94 ± 1.70
Identification of risk factors (6) 4.8 ± 1.41
CVD risk assessment (16) 14.6 ± 0.91
Process of risk management – physicians (4) 2.36 ± 0.88
Process of risk management – patients (5) 1.63 ± 1.27
tAble 4. Principal components loading, eigenvalues, and 
explained variance in the principal component analysis of the 
process of the cardiovascular prevention in cross-sectional 
study of high risk patients for cardiovascular disease in slovenia
components and loadings
Variables of the process 1 2 3 4 5
Identification of patients   0.59   0.56  -0.09  -0.57   0.09
Identification of risk factors   0.71  -0.52  -0.07  -0.09  -0.47
Risk assessment   0.51   0.54  -0.48   0.47  -0.04
Risk management – physicians   0.48   0.30  -0.79   0.22  -0.03
Risk management – patients   0.68  -0.56  -0.06   0.08   0.46
λ – eigenvalue   1.80   1.27   0.87   0.61   0.44
σ2 – percentage of explained 
variance
36.10 25.44 17.44 12.13   8.90
Figure 2.
scree diagram of the principal component analysis of the process of car-
diovascular disease prevention in the cross-sectional study of high risk 
patients for cardiovascular disease in slovenia.PUBLIC HEALTH 724 Croat Med J. 2011; 52: 718-27
www.cmj.hr
education on CVD. Among several patients’ characteristics 
that were tested, only socioeconomic status and age were 
important, both pointing to the groups of patients that 
need more attention.
Our results are in line with the article by Mant (15), who 
stated that the process measurement was relatively inde-
pendent of the extrinsic factors such as patient character-
istics or their life-style, and is sensitive to differences in the 
quality of care. We explained an important part of variabil-
ity of the process of CVD prevention with proposed prac-
tice and physicians’ characteristics and only a small part 
with patient characteristics.
Special  attention  when  conducting  preventive  activi-
ties should be given to patients with poor financial cir-
cumstances since a low socioeconomic status has a well 
known (16,17) and multifactorial (18) influence on high-
er incidence of CVD, due to a more frequent presence 
of some risk factors, such as smoking. Also, the most fre-
quently used risk assessment forms (Framingham, Score) 
are more likely to identify high CVD risk in higher socioeco-
nomic groups (18). Our results showed that FPs are prob-
ably aware of these facts, because the socioeconomic sta-
tus is not part of the system of the CVD prevention and a 
better process of CVD prevention could be a result of op-
portunity screening.
One of the most consistent critiques of our national pre-
ventive program is that the eligible patients are too old. 
According to our results, physicians offer a better pro-
cess of CVD prevention to younger patients who enter 
the preventive program. Nevertheless, the average age of 
study patients is 63 years, which makes this conclusion of 
relative value. The average age of Slovenian participants 
of the international part of the EPA-Cardio study is similar 
tAble 5. Regression coefficients of the multilevel prediction model for the process of cardiovascular prevention with the characteris-
tics of patients, physicians, and practices in cross-sectional study of high risk patients for cardiovascular disease in slovenia
estimate (95% confidence interval) standard error t-value
intercept (number of original variables) -0.473 (-1.117-0.171) 0.261    -1.82
Patients’ variables (13):  
sex (female) -0.036 (-0.125-0.053) 0.045 -0.79
age -0.013 (-0.018 to -0.008) 0.003 -4.94*
education    0.011 (-0.051-0.073) 0.032     0.34
socioeconomic status -0.103 (-0.195 to -0.010) 0.047 - 2.18*
employment (unemployed)    0.095 (-0.122-0.312) 0.110     0.86
marital status (married)    0.057 (-0.040-0.154) 0.049     1.16
ethnic origin (Slovenian) -0.083 (-0.247-0.080) 0.083   -1.0 0
self-rating of health -0.025 (-0.092-0.042) 0.034 -0.73
quality of life -0.002 (-0.034-0.031) 0.016 -0.09
length of attachment -0.011 (-0.060-0.037) 0.025 -0.46
frequency of visits    0.017 (-0.016-0.051) 0.017     1.01
chronic diseases    0.019 (-0.037-0.076) 0.029     0.67
regular intake of medication    0.007 (-0.025-0.039) 0.016     0.45
Physicians’ variables (3):
cooperation in programs of cardiovascular disease (CVD) prevention(yes)    0.401 (-0.076-0.879) 0.188    2.14
physician’s age    0.025 (-0.008-0.058) 0.013     1.90
physician’s sex (female) -0.032 (-0.650-0.586) 0.243 -0.13
Practices variables (8):
practice location (urban)    0.425 (-0.111-0.961) 0.211    2.02
practice size (small)    0.615 (0.063-1.166) 0.217    2.83*
information system for CVD    0.156 (0.030-0.282) 0.050     3.15*
organization of prevention    0.072 -(0.164-0.307) 0.093     0.77
access to information    0.080 -(0.415-0.575) 0.195     0.41
cooperation of practice in CVD projects -0.168 -(0.440-0.105) 0.107    -1.56
organization of education    0.212 (0.043-0.380) 0.066     3.19*
workload in practice    0.000 (0.000-0.000) 0.000     0.24
*statistical significance (95% confidence intervals not containing the zero-value).725 Petek et al: Predictors of the quality of cardiovascular prevention
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to other countries (19), but high for primary prevention 
activities.
Multivariate analyses found that the most numerous and im-
portant independent predictors of the process were practice 
characteristics, such as good information systems, including 
standardization of risk assessment, systematic organization 
of medical records, and standard classification systems of 
the diseases. Other studies have also found that an impor-
tant predictor is better information technology (20-23).
Another important predictor was organization of educa-
tion on CVD. Most of the FPs in the country are employed 
in the public health care centers and their individual edu-
cation plans are coordinated by the practice management. 
Better education plays a role in the improvement of the 
quality of the service. We believe that this is an important 
finding, which is also in line with the results of other stud-
ies:  continuous  medical  education  has  recently  gained 
high importance in Central and Eastern European coun-
tries including Slovenia (24) and a lower availability of con-
tinuous medical education options is often perceived by 
FPs as a potential threat to professional development (25).
Smaller practices showed better quality of CVD prevention. 
The size of the practices in many European countries has 
increased in the last decade and larger practices can offer a 
wider range of activities (26,27). However, smaller practices 
have to rely on themselves in order to fulfill the obligations 
to the national preventive program, especially as many of 
them are private contractors.
No physicians’ characteristic was a predictor of a better 
process of CVD prevention. One predictor that was close to 
statistical significance, with high t value, was the FPs’ pro-
fessional activity – working in CVD preventive projects. It is 
possible that in a larger sample, these characteristics could 
become an important predictor, as well as location of the 
practice (urban vs rural).
We  presented  one  possible  model  for  measuring  the 
quality of the process of prevention. It is a broad predic-
tion  model,  which  comprehensively  takes  into  account 
numerous factors related to the practice, physicians, and 
patients  (28).  Using  PCA,  we  also  revealed  the  internal 
structure of the data. The first component was defined by 
the identification of the patients and risk factors, risk as-
sessment, and risk management. Therefore, we conclude 
that the first component measures the overall process of 
CVD prevention. With the development of the process as 
a quality-measuring variable represented by defined com-
pound sub-variables, ie, consecutive steps of the process, 
we could use the majority of the data that are important 
for the quality in the CVD prevention process.
Another advantage of our approach is that the data came 
from different sources. The data for the identification of risk 
factors and risk management came from medical records, 
but the data on risk identification and methods for risk as-
sessment, and some data on risk management, came from 
interviews with physicians. Therefore, we were able to as-
sess the quality not only with the data from the medical 
records, but also by combining physicians’ reports on their 
performance with the patients’ personal and health char-
acteristics.
A  64%  response  rate  from  the  selection  of  practices  is 
enough to claim that the study is representative, although 
the selection could be biased toward the practices with 
more interest in prevention activities. Another limitation 
could be the fact that we used the Framingham risk score 
for evaluating CVD risk morbidity. It is known that it sys-
tematically overestimates the risk of coronary heart disease 
in populations with lower coronary heart disease mortality 
(29). Slovenia is still among the European countries with 
higher coronary heart disease mortality, and no studies 
evaluate the Framingham risk score specifically for Slove-
nia. A national agreement was reached to use the Framing-
ham risk score for risk evaluation of CVD in the National 
preventive program. Therefore, it was feasible to select the 
patients on the basis of the Framingham risk evaluation.
According to our results, the process of CVD prevention is 
more or less dependent on the practice organization and its 
orientation toward preventive services, which are not spe-
cifically dependent on patients’ characteristics. Neverthe-
less, some patients’ groups need special attention, such as 
those of lower socioeconomic class. On the one hand, this 
gives us confidence that physicians are taking great pains 
to provide patients with appropriate care regardless the pa-
tients’ individual characteristics, but on the other it seems 
that full responsibility for the quality of the CVD prevention 
process rests upon the physicians and practices. However, it 
is plausible that other patients’ characteristics influence the 
outcome of the prevention, as we did not study the long-
term outcomes of prevention programs (15,30,31) or pa-
tient adherence to lifestyle changes (32-34).
Further  prospective  epidemiological  cohort  studies 
should address the question of quality of cardiovas-PUBLIC HEALTH 726 Croat Med J. 2011; 52: 718-27
www.cmj.hr
cular prevention. On the basis of our results, we cannot 
conclude how a good process of cardiovascular preven-
tion relates to the outcomes of CVD prevention, measured 
in healthy life style and regulated risk factors for CVD. We 
present one possible model for quality evaluation of CVD 
prevention and this model could be further tested in inter-
national studies.
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